Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023. Lilly didn’t ...

Eli Lilly. "Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance." Eli Lilly. "Lilly Provides Update on 2024 Revenue Guidance, Announces 2025 Revenue Guidance." ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

The Pulitzer Prize-winning play “English” opened on Broadway just days after Donald Trump took office for the second time — which was notable timing for a show that had it roots in the early ...

Eli Lilly, BCE, Suncor, Canada Goose ... After a limited version of the rules were set in late 2023, Bell responded by announcing it would cut network investment plans by more than $1 billion ...

You're welcome. Out the front of The Pulitzer, Amsterdam As a journalist, I’ve reviewed my fair share of hotels. Finding a base in a city to explore from that doesn’t feel sterile and this ...

Eli Lilly and Company (NYSE ... U.S. for two types of inflammatory bowel disease (IBD), following its October 2023 approval as a first-in-class treatment for moderately to severely active ...

Jay is a clinical psychologist who was married to Slater from 2018 until their 2023 divorce ... Ethan Slater & Lilly Jay Jason Smith/Everett Collection. In her essay in The Cut, Jay spoke about ...

The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based therapies Mounjaro for diabetes and Zepbound for obesity ...